These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Liquid-chromatographic detection of aspartylglycosaminuria. Mononen T; Parviainen M; Penttilä I; Mononen I Clin Chem; 1986 Mar; 32(3):501-2. PubMed ID: 3948393 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family. Gehler J; Sewell AC; Becker C; Hartmann J; Spranger J Helv Paediatr Acta; 1981; 36(2):179-89. PubMed ID: 6788730 [TBL] [Abstract][Full Text] [Related]
7. Automated ion-exchange chromatography in the detection of aspartylglucosaminuria. Marnela KM J Chromatogr; 1980 Jun; 182(3-4):409-13. PubMed ID: 7391183 [No Abstract] [Full Text] [Related]
8. Aspartylglycosaminuria in an Italian family: clinical and biochemical characteristics. Gehler J; Sewell AC; Becker C; Spranger J; Hartmann J J Inherit Metab Dis; 1981; 4(4):229-30. PubMed ID: 6796777 [TBL] [Abstract][Full Text] [Related]
12. Abnormal dermal proteoglycan in aspartylglycosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder. Näntö-Salonen K; Larjava H; Säämanen AM; Heino J; Penttinen R; Pelliniemi LJ; Tammi M Connect Tissue Res; 1987; 16(4):367-76. PubMed ID: 3132350 [TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria. Aula P; Rapola J; von Koskull H; Ammälä P Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a mannose-containing glycoasparagine isolated from urine of a patient with aspartylglycosylaminuria (AGU). Akasaki M; Sugahara K; Funakoshi I; Aula P; Yamashina I FEBS Lett; 1976 Oct; 69(1):191-4. PubMed ID: 992027 [No Abstract] [Full Text] [Related]
15. Regional distribution of glycoasparagine storage material in the brain in aspartylglycosaminuria. Maury CP; Haltia M; Palo J J Neurol Sci; 1981 May; 50(2):291-8. PubMed ID: 6164750 [TBL] [Abstract][Full Text] [Related]
16. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes. Näntö-Salonen K; Halme T; Penttinen R; Langevelde FV; Vis RD; Alfthan G J Inherit Metab Dis; 1985; 8(4):212-8. PubMed ID: 3939546 [TBL] [Abstract][Full Text] [Related]
17. Identification of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in biological materials by gas chromatography-mass spectrometry. Maury P; Kärkkäinen J Clin Chim Acta; 1979 Jan; 91(1):75-9. PubMed ID: 761395 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of 4-N-2-acetamido-2-deoxy-beta-D-glucopyranosyl-L-asparagine in the urine of patients with aspartylglycosaminuria by gas-liquid chromatography. Maury P J Lab Clin Med; 1979 May; 93(5):718-23. PubMed ID: 429870 [TBL] [Abstract][Full Text] [Related]
19. [Skeletal changes in 2 German children with aspartylglycosaminuria]. Schmidt H; Ziegler R; Ullrich K; von Lengerke JH; Sewell AC Rofo; 1988 Aug; 149(2):143-6. PubMed ID: 2842830 [TBL] [Abstract][Full Text] [Related]
20. Aspartylglucosaminuria in a Canadian family. Gordon BA; Rupar CA; Rip JW; Haust MD; Coulter-Mackie MB; Scott E; Hinton GG Clin Invest Med; 1998 Jun; 21(3):114-23. PubMed ID: 9627765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]